Bethesda, Md. – AABB’s National Blood Foundation (NBF) will convene executives in the fields of transfusion medicine, cellular therapies and patient blood management to discuss the most pertinent issues currently affecting the blood community at the upcoming NBF Leadership Forum, to be held on March 20, 2018, in Scottsdale, Ariz.
Blood community leaders will discuss critical industry challenges, including protecting patient and donor data from a cyber-attack, emergency preparedness for catastrophic events, business diversification and novel partnerships, and Medicare reimbursement and alternative payment models. The gathering is designed to ensure that blood community leaders hear from experts to better prepare for existing challenges, including decline in blood usage, unpredictable cyber threats and increasing catastrophic events, and be well-positioned to face new ones in the future.
The NBF Leadership Forum will be facilitated by Mary Beth Bassett, BS, MT(ASCP), AABB president and Executive Vice President and Chief Quality Officer at Blood Systems, and will feature sessions led by experts from leading organizations, including:
- America’s Blood Centers
- Arizona Department of Health Services
- Blood Systems, Inc.
- Community Blood Center of Greater Kansas City
- Cronkite News – Arizona State University
- Fresenius Kabi
- Manatt Health
- New York Blood Center
- San Diego Blood Bank
- Southern Texas Regional Advisory Council
- Terumo BCT
The Arizona Republic
- University Medical Center of Southern Nevada
“The NBF Leadership Forum addresses key issues currently shaping our industry,” Bassett said. “Future leaders in the blood community are invited to attend and participate in conversations that will foster new ideas, support our priority issues and promote innovations that advance this critical work.”
AABB’s National Blood Foundation (NBF), established in 1983, serves the fields of transfusion medicine and cellular therapies through grant making, educational offerings and industry leadership engagement and recognition. The NBF has provided more than $9 million in early-career grants and has funded more than 200 research grants – propelling its recipients to rank in the top 10th percentile for NIH R01 Funding.
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.